Paper35705369
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases.
Sullivan KM and 22 others. Gut, 2023. Cited by 124 papers, by iCite.
Cite this record
ConductScience Library. Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. Papers, record 35705369. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35705369
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Colorectal Neoplasms | Major topic |
| Interleukin-10 | Major topic |
| Liver Neoplasms | Major topic |
| Receptors, Chimeric Antigen | Major topic |
| Receptors, Interleukin-10 | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Carcinoembryonic Antigen | |
| CD8-Positive T-Lymphocytes | |
| Immunotherapy, Adoptive | |
| Lymphocyte Activation | |
| Receptors, Antigen, T-Cell | |
| Antibodies, Blocking |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA015704 | NCI NIH HHS | United States | P30CA015704 | PubMed and NIH | NIH RePORTER |
| R01 CA190122 | NCI NIH HHS | United States | R01CA190122 | PubMed and NIH | NIH RePORTER |
| S10 OD016240 | NIH HHS | United States | S10OD016240 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 42362223 | Correction: Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. | https://conductscience.org/library/papers/42362223 |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30755454 | Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease. | J Exp Med | 2019 | https://conductscience.org/library/papers/30755454 | PubMed |
| 2 | 32934073 | Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses. | Sci Signal | 2020 | https://conductscience.org/library/papers/32934073 | PubMed |
| 3 | 30465211 | Establishment of Slice Cultures as a Tool to Study the Cancer Immune Microenvironment. | Methods Mol Biol | 2019 | https://conductscience.org/library/papers/30465211 | PubMed |
| 4 | 29296022 | Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution. | Nat Commun | 2018 | https://conductscience.org/library/papers/29296022 | PubMed |
| 5 | 25850950 | Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases. | Clin Cancer Res | 2015 | https://conductscience.org/library/papers/25850950 | PubMed |
| 6 | 27199222 | Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases. | Cancer Gene Ther | 2016 | https://conductscience.org/library/papers/27199222 | PubMed |
| 7 | 31611251 | Biology and therapeutic potential of interleukin-10. | J Exp Med | 2020 | https://conductscience.org/library/papers/31611251 | PubMed |
| 8 | 9182682 | Altered immune responses in interleukin 10 transgenic mice. | J Exp Med | 1997 | https://conductscience.org/library/papers/9182682 | PubMed |
| 9 | 34031618 | Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity. | Nat Immunol | 2021 | https://conductscience.org/library/papers/34031618 | PubMed |
| 10 | 22123924 | Interleukin-10 ablation promotes tumor development, growth, and metastasis. | Cancer Res | 2012 | https://conductscience.org/library/papers/22123924 | PubMed |
| 11 | 28366766 | Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers. | Mol Ther | 2017 | https://conductscience.org/library/papers/28366766 | PubMed |
| 12 | 22945653 | Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays. | Oncogene | 2013 | https://conductscience.org/library/papers/22945653 | PubMed |
| 13 | 22581824 | IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs. | Cancer Res | 2012 | https://conductscience.org/library/papers/22581824 | PubMed |
| 14 | 28691930 | Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28691930 | PubMed |
| 15 | 30537506 | The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients. | Cancer Cell | 2018 | https://conductscience.org/library/papers/30537506 | PubMed |
| 16 | 19165197 | Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. | Br J Cancer | 2009 | https://conductscience.org/library/papers/19165197 | PubMed |
| 17 | 29334918 | Colorectal cancer liver metastases - a population-based study on incidence, management and survival. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29334918 | PubMed |
| 18 | 22658128 | Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22658128 | PubMed |
| 19 | 33230244 | Monocytic and granulocytic myeloid-derived suppressor cell plasticity and differentiation are organ-specific. | Oncogene | 2021 | https://conductscience.org/library/papers/33230244 | PubMed |
| 20 | 23010736 | Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. | Ann Surg Oncol | 2013 | https://conductscience.org/library/papers/23010736 | PubMed |
Cited by104
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42925343 | Histopathological growth patterns represent a dynamic biological and clinically-relevant terminus of the metastatic cascade. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42925343 | PubMed |
| 42909684 | Biomarkers and future directions for immunotherapy in microsatellite-stable colorectal cancer: a systematic review. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42909684 | PubMed |
| 42828741 | Rapid selection of high-affinity DARPins using click display. | Protein Eng Des Sel | 2026 | https://conductscience.org/library/papers/42828741 | PubMed |
| 42706236 | B cells in cancer: functions, mechanisms and therapeutic advances. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42706236 | PubMed |
| 42588588 | Locoregional Therapy Pressure-Enabled Drug Delivery for Liver Cancers. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588588 | PubMed |
| 42557624 | An Engineered Bacterial Platform Combining Photothermal Ablation with Immunogenic Cell Death and Microenvironment Remodeling for Synergistic Tumor Therapy. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42557624 | PubMed |
| 42495635 | Macroscopic fractal dynamics characterize the "physical-metabolic" dual barriers and systemic immune exhaustion associated with primary resistance to immunotherapy in liver metastases. | Front Immunol | 2026 | https://conductscience.org/library/papers/42495635 | PubMed |
| 42368560 | Targeting cytokine/chemokine signaling to convert immunologically cold tumors into hot: Emerging strategies in cancer immunotherapy. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42368560 | PubMed |
| 42358994 | Colorectal cancer liver metastasis: immunosuppressive microenvironment, signaling pathways, and emerging therapeutic strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42358994 | PubMed |
| 42233094 | The multifaceted landscape of T cell exhaustion in organ transplantation: From molecular mechanisms (epigenetics, transcription, metabolism) to induction strategies. | Genes Dis | 2026 | https://conductscience.org/library/papers/42233094 | PubMed |
| 42131111 | Organoids glimpse: the nexus for diverse tumor heterogeneity. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42131111 | PubMed |
| 42035162 | Overcoming blood-brain barrier and chemoresistance in glioblastoma by Angiopep-2-modified NK cell-derived extracellular vesicles for targeted delivery of temozolomide. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42035162 | PubMed |
| 41981680 | Autologous tumor-immune effusion cocultures enable ex vivo functional profiling of radiotherapy-immunotherapy combinations. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/41981680 | PubMed |
| 41975016 | Progress in Designing Cytokine Antagonist Antibodies for Cancer Therapy. | BioDrugs | 2026 | https://conductscience.org/library/papers/41975016 | PubMed |
| 41965925 | Potential role of leptin in colorectal cancer liver metastasis involving lipid metabolic reprogramming and immunosuppressive macrophage polarization. | Sci Rep | 2026 | https://conductscience.org/library/papers/41965925 | PubMed |
| 41965798 | Concurrent sigmoid colon adenocarcinoma presenting with cutaneous adult T-cell leukemia/lymphoma: a rare case report. | Infect Agent Cancer | 2026 | https://conductscience.org/library/papers/41965798 | PubMed |
| 41947122 | Nanomedicine in immunotherapy of urinary system tumors: advances, synergistic strategies, and translational challenges. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41947122 | PubMed |
| 41939884 | The metabolic environment within solid tumors drives a complex crosstalk between macrophages and NK cells. | Front Immunol | 2026 | https://conductscience.org/library/papers/41939884 | PubMed |
| 41800035 | Research progress on resistance mechanisms to CAR-T cell therapy in diffuse large B-cell lymphoma. | Front Oncol | 2026 | https://conductscience.org/library/papers/41800035 | PubMed |
| 41527110 | Correlation and combined predictive value analysis of serum IL-6 and IL-10 levels with tumor progression in patients with cervical cancer. | Eur J Med Res | 2026 | https://conductscience.org/library/papers/41527110 | PubMed |
Genes60
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| Dryad | 10.5061/dryad.0cfxpnw54 |
Source Dryad
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35705369
GET https://conductscience.org/api/papers/v1/35705369/authors?page=2